CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics
Oct 23, 2018
CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) in China
Aug 14, 2018
CANbridge Life Sciences Appoints Chief Medical Officer
Jul 31, 2018
CANbridge Life Sciences Appoints Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance
May 08, 2018
CANbridge Receives China Food and Drug Administration Approval for CAN002 as Cancer Adjuvant Therapy
Apr 26, 2018
CANbridge Receives Approval to Commence CAN008 Phase II/III Trial in Glioblastoma Multiforme (Gbm) in China
Apr 12, 2018
Industry Veteran Joins CANbridge Life Sciences Advisory Team
Feb 13, 2018
Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize Nerlynx® (Neratinib) in Greater China
Feb 02, 2018
CANbridge Appoints Sunny Zhang as Vice President of Regulatory Affairs and Quality
Jan 16, 2018